Zotefoams Valuation Multiples

Discover Zotefoams' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Canatu, Accsys, Metal Powder Works, Australian Strategic Materials and more.

Zotefoams Overview

About Zotefoams

Zotefoams PLC is engaged in the manufacturing of polymer foam using bespoke autoclave technology to produce foams with attributes. Its block foams are sold under the AZOTE, T-FIT, ZOTEK, and other brand names. The company serves automotive, aerospace, packaging, industrial parts, marine, building and construction, military, medical, and sports and leisure industries. It has three main operating segments Polyolefin foams, High-Performance Products, and MuCell Extrusion LLC. The maximum revenue to the company is generated from the High-Performance Products.


Founded

1992

HQ

United Kingdom

Employees

569

Financials (LTM)

Revenue: $238M
EBITDA: $49M

EV

$348M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Zotefoams Financials

Zotefoams reported last 12-month revenue of $238M and EBITDA of $49M.

In the same LTM period, Zotefoams generated $49M in EBITDA and $25M in net income.

Revenue (LTM)


Zotefoams P&L

In the most recent fiscal year, Zotefoams reported revenue of $213M and EBITDA of $44M.

Zotefoams is profitable as of last fiscal year, with gross margin of 33%, EBITDA margin of 21%, and net margin of 14%.

See analyst estimates for Zotefoams
LTMLast FY202320242025202620272028
Revenue$238M$213M$171M$199M$213M
Gross Profit-$71M$55M$62M$71M
Gross Margin-33%32%31%33%
EBITDA$49M$44M$32M$17M$41M
EBITDA Margin21%21%19%8%19%
EBIT Margin15%14%12%12%14%
Net Profit$25M$30M$12M($4M)$30M
Net Margin11%14%7%(2%)14%
Net Debt-$42M---

Financial data powered by Morningstar, Inc.

Zotefoams Stock Performance

Zotefoams has current market cap of $290M, and enterprise value of $348M.

Market Cap Evolution


Zotefoams' stock price is $5.90.

Zotefoams share price increased by 1.2% in the last 30 days, and by 59.0% in the last year.

Zotefoams has an EPS (earnings per share) of $0.62.

See more trading valuation data for Zotefoams
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$348M$290M0.5%1.2%10.5%59.0%$0.62

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Zotefoams Valuation Multiples

Zotefoams trades at 1.5x EV/Revenue multiple, and 7.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Zotefoams

EV / Revenue (LTM)


Zotefoams Financial Valuation Multiples

As of July 19, 2026, Zotefoams has market cap of $290M and EV of $348M.

Zotefoams has a P/E ratio of 11.4x.

LTMLast FY202320242025202620272028
EV/Revenue1.5x1.6x2.0x1.8x1.6x
EV/EBITDA7.1x7.9x11.0x21.1x8.4x
EV/EBIT10.0x11.4x17.1x14.3x11.5x
EV/Gross Profit-4.9x6.3x5.6x4.9x
P/E11.4x9.5x23.4x(78.4x)9.5x
EV/FCF34.8x12.4xn/m22.8x12.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Zotefoams Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Zotefoams Margins & Growth Rates

Zotefoams grew revenue by 21% and EBITDA by 20% in the last fiscal year.

In the most recent fiscal year, Zotefoams reported gross margin of 33%, EBITDA margin of 21%, and net margin of 14%.

See estimated margins and future growth rates for Zotefoams

Zotefoams Margins

Last FY202420252026202720282029
Gross Margin33%31%33%-
EBITDA Margin21%8%19%21%
EBIT Margin14%12%14%15%
Net Margin14%(2%)14%10%
FCF Margin13%8%13%(1%)

Zotefoams Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth21%16%7%21%
Gross Profit Growth-12%15%-
EBITDA Growth20%(48%)150%28%
EBIT Growth25%20%24%26%
Net Profit Growth(14%)(130%)(922%)(14%)
FCF Growth(105%)(1717%)84%(105%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Zotefoams Operational KPIs

Zotefoams' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Zotefoams' Rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Zotefoams' Rule of X is 73% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Zotefoams
LTMLast FY202320242025202620272028
Rule of 4033%42%---
Bessemer Rule of X51%73%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-5%6%6%5%
G&A Expenses to Revenue13%14%14%13%14%
Opex to Revenue-19%20%19%19%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Zotefoams Competitors

Zotefoams competitors include Canatu, Accsys, Metal Powder Works, Australian Strategic Materials, NanoXplore, Advanced Innergy Holdings, Aspen Aerogels, Electrovac, Mativ Holdings and Luxfer Holdings.

Most Zotefoams public comparables operate across Advanced Materials and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Canatu9.8x8.1x(21.8x)(18.2x)
Accsys1.6x1.6x11.8x11.2x
Metal Powder Works183.7x75.0x(85.1x)(54.9x)
Australian Strategic Materials67.1x-(10.1x)-
NanoXplore2.2x2.4x46.0x117.5x
Advanced Innergy Holdings1.3x0.9x-5.7x
Aspen Aerogels1.4x1.7x129.4x(36.0x)
Electrovac1.3x1.1x9.0x6.7x

This data is available for Pro users. Sign up to see all Zotefoams competitors and their valuation data.

Start Free Trial

Acquisitions by Zotefoams

Zotefoams has acquired 1 company to date.

Last acquisition by Zotefoams was on January 6th 2017. Zotefoams acquired KunShan ZOTEK King Lai Co. Ltd. for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Zotefoams

KunShan ZOTEK King Lai Co. Ltd.
Description
KunShan ZOTEK King Lai Co. Ltd. is a Kunshan-headquartered producer of closed-cell foam insulation products in Jiangsu Province, China. The company manufactures polyethylene and cross-linked foams for construction, automotive, and packaging applications, supplying domestic and international markets with thermal and shock-absorption materials.
HQ CountryChina
HQ City
Kunshan
Deal Date6 Jan 2017
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Zotefoams acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Zotefoams

When was Zotefoams founded?Zotefoams was founded in 1992.
Where is Zotefoams headquartered?Zotefoams is headquartered in United Kingdom.
How many employees does Zotefoams have?As of today, Zotefoams has over 569 employees.
Who is the CEO of Zotefoams?Zotefoams' CEO is Ronan Michael Cox.
Is Zotefoams publicly listed?Yes, Zotefoams is a public company listed on London Stock Exchange.
What is the stock symbol of Zotefoams?Zotefoams trades under ZTF ticker.
When did Zotefoams go public?Zotefoams went public in 1995.
Who are competitors of Zotefoams?Zotefoams main competitors include Canatu, Accsys, Metal Powder Works, Australian Strategic Materials, NanoXplore, Advanced Innergy Holdings, Aspen Aerogels, Electrovac, Mativ Holdings, Luxfer Holdings.
What is the current market cap of Zotefoams?Zotefoams' current market cap is $290M.
What is the current revenue of Zotefoams?Zotefoams' last 12 months revenue is $238M.
What is the current revenue growth of Zotefoams?Zotefoams revenue growth (NTM/LTM) is 12%.
What is the current EV/Revenue multiple of Zotefoams?Current revenue multiple of Zotefoams is 1.5x.
What is the current EBITDA of Zotefoams?Zotefoams' last 12 months EBITDA is $49M.
What is Zotefoams' EBITDA margin?Zotefoams' last 12 months EBITDA margin is 21%.
What is the current EV/EBITDA multiple of Zotefoams?Current EBITDA multiple of Zotefoams is 7.1x.
What is the current FCF of Zotefoams?Zotefoams' last 12 months FCF is $10M.
What is Zotefoams' FCF margin?Zotefoams' last 12 months FCF margin is 4%.
What is the current EV/FCF multiple of Zotefoams?Current FCF multiple of Zotefoams is 34.8x.
How many companies Zotefoams has acquired to date?As of July 2026, Zotefoams has acquired 1 company.
What was the largest acquisition by Zotefoams?None of the M&A deals Zotefoams has completed have disclosed valuations.
What companies Zotefoams acquired?Zotefoams acquired KunShan ZOTEK King Lai Co. Ltd..
In how many companies Zotefoams has invested to date?Zotefoams hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Zotefoams

Lists including Zotefoams

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial